{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:55:39Z","timestamp":1782755739118,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.clinbiochem.2015.06.020","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T09:29:47Z","timestamp":1435742987000},"page":"1113-1119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia"],"prefix":"10.1016","volume":"48","author":[{"given":"Josef","family":"van Helden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0005","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(00)02800-2","article-title":"Pre-eclampsia","volume":"356","author":"Walker","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0015","series-title":"Hypertension in pregnancy","year":"2013"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenetic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0025","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenetic factors and implications of later cardiovascular disease","volume":"1213","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0035","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placental growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejogrb.2004.11.015","article-title":"Circulating concentrations of s-Flt-1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during preeclampsia","volume":"122","author":"Staff","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PlGF ration in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"469","key":"10.1016\/j.clinbiochem.2015.06.020_bb0055","first-page":"e1","article-title":"Angiogenic factors as a diagnostic test for preeclampsia: a performance comparison between two commercial immunoassays","volume":"205","author":"Benton","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0060","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/clinchem\/39.9.1953","article-title":"Rare earth cryptates and homogeneous fluoroimmunoassays with human sera","volume":"39","author":"Mathis","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01243160","article-title":"Tris (2,2\u2032-bipyridyl)ruthenium(II) electrogenerated chemiluminescence in analytical science","volume":"127","author":"Lee","year":"1997","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0070","first-page":"49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1515\/CCLM.2004.077","article-title":"Multicenter evaluations of a new immunoassay for procalcitonin measurement on the Kryptor system","volume":"42","author":"Steinbach","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0080","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I","volume":"21","author":"Passing","year":"1983","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"8","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2010.02.010","article-title":"Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia","volume":"43","author":"Schiettecatte","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jash.2014.11.008","article-title":"Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1\/placental growth factor ratio: an inter-assay comparison","volume":"9","author":"Anderson","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000358595","article-title":"Maternal serum placental growth factor isoforms 1 and 2 at 11\u201313, 20\u201324 and 30\u201334weeks' gestation in late onset pre-eclampsia and small of gestational age neonates","volume":"35","author":"Nucci","year":"2014","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000357842","article-title":"Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11\u201313weeks' gestation in normal and pathological pregnancies","volume":"36","author":"Nucci","year":"2014","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.clinbiochem.2015.06.020_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0032-1328601","article-title":"Prenatal clinical assessment of sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio as a diagnostic tool for preeclampsia, pregnancy-induced hypertension, and proteinuria","volume":"73","author":"Lehnen","year":"2013","journal-title":"Geburtshilfe Frauenheilkd."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015002581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015002581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:47:01Z","timestamp":1757864821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015002581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":23,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0009912015002581"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.06.020","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}